Collaboration

Laboratory research
#Cancer research #Collaboration #Drug discovery #Oncology #Partnership #Target identification #Target validation

Partners from UK and Singapore agree cancer drug discovery deal

Cancer Research Horizons and Singapore’s Experimental Drug Development Centre (EDDC) have announced a five-year strategic partnership to accelerate the translation of cancer research into improved treatments for cancer patients.   The international alliance will focus on leveraging the complementary capabilities, platforms and technologies from both partners, to accelerate… Read More

#Cancer Research #News

DNA sequencing
#Collaboration #Genetics / genomics #Genome sequencing #High throughput screening #Lab automation #Library screening #Oxford Nanopore Technologies #Partnership #The Tecan Group

Alliance hopes to automate nanopore library preparation

The Tecan Group and Oxford Nanopore Technologies will collaborate to drive easier high throughput nanopore library preparation in an automated, hands-free fashion.   The aim of the partnership is a fully automated workflow for Oxford Nanopore’s Ligation Sequencing Kit XL V14 protocol (LSK114) with Tecan’s DreamPrep NGS solutions. Read More

#Business & Investment #News

Clostridioides difficile
#Collaboration #Destiny Pharma #Partnership #Phase III trial #Sebela Pharmaceuticals

Companies agree up to $570m deal for C difficile drug

Under a new agreement, Destiny Pharma and Sebela Pharmaceuticals will co-develop NTCD-M3, Destiny’s lead asset for the prevention of Clostridioides difficile infection (CDI) recurrence.  It is anticipated that Sebela will lead and finance the future clinical development and commercialisation activities of NTCD-M3 in North America.  … Read More

#Business & Investment #News

Laboratory technology
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Charles River #Collaboration #DNA technology #High throughput screening #Medicinal chemistry #Partnership #Pioneering Medicines

Partners enter multi-programme drug discovery agreement

Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica.  Through the agreement, Pioneering Medicines will apply Logica across a portfolio of targets with the aim of creating optimised small molecules… Read More

#News

Gene editing
#Collaboration #CRISPR #Genetics / genomics #GenScript #Indee Labs #Partnership

Companies unite to advance non-viral CRISPR cell engineering

Indee Labs and GenScript have formed a research collaboration with the aim to develop a DNA knock-in kit for Hydropore to enable large transgene inserts above the 5kb limit for AAV.  As part of the collaboration, GenScript will provide a variety of single-strand and double-strand (ssDNA and… Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #Collaboration #Drug development #Drug discovery #Oncology #Partnership

This week in drug discovery (13-17 February)

News round-up for 13-17 February by DDW Digital Content Editor Diana Spencer.  The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of… Read More

#News

Big genomic data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Bioinformatics #Collaboration #Genetics / genomics #Oncology #Partnership

Partners hope to “chart a new era of drug discovery”

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments.  In this partnership, M2GEN will license its real-world data set (RWD) to Zephyr AI, while Zephyr AI will… Read More

#Cancer Research #News

Liquid handler in laboratory
#Automata #Automated workflows #Automation #Automation / robotics #Collaboration #Genetics / genomics #Lab automation #Partnership #The Francis Crick Institute

Automation for genomics could accelerate discovery

A collaboration between Automata and the Advanced Sequencing Facility (ASF) at The Francis Crick Institute hopes to unlock the power of integrated automation for genomics sample preparation.  Genomics sample preparation workflows are ideally suited for automation given the need for robustness and scalability.   The teams… Read More

#Business & Investment #News

Research laboratory
#Astex Pharmaceuticals #Cardiff University #Collaboration #Fragment-based drug discovery #Neurodegenerative disorders #Partnership

Multimillion pound collaboration targets neurodegeneration

Astex Pharmaceuticals and The Medicines Discovery Institute, Cardiff University (MDI) have agreed a multi-year, multimillion pound drug discovery research collaboration, aimed to identify new drugs to treat neurodegenerative diseases.    The collaboration brings together the research expertise of Dr Emyr Lloyd-Evans and Dr Helen Waller-Evans in lysosomal biology,… Read More

#Business & Investment #News

Protein degradation
#Collaboration #DNA #Kymera Therapeutics #Library screening #Partnership #Protein chemistry / Proteomics #X-Chem

X-Chem and Kymera expand partnership to 12 targets

X-Chem and Kymera Therapeutics have expanded their collaboration, which will now comprise 12 targets and grants Kymera exclusive rights to compounds discovered within the collaboration.   With the expanded agreement, X-Chem will serve as the primary provider of DNA-encoded library (DEL)-based screening services to Kymera – using its… Read More

#Business & Investment #News

Flow cytometry
#Bio-Rad Laboratories #Collaboration #Cytek Biosciences #Flow Cytometry #Partnership #Reagents

Partnership will expand reagent portfolios

Cytek Biosciences and Bio-Rad Laboratories have entered into a strategic development partnership.   Under the terms of the agreement, Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialise reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems. … Read More

#News

G-protein coupled receptors
#Assay development optimisation & technology #Collaboration #Endevica #Orbit Discovery #Partnership

Multi-target collaboration to advance cachexia therapeutics

A new collaboration aims to accelerate development of advanced G-protein coupled receptor (GPCR)-targeting therapeutics for cachexia caused by cancer and other chronic conditions.  Orbit Discovery has entered a partnership with Endevica Bio following the release of data proving that the company’s lead compound is safe and well-tolerated… Read More

#Business & Investment #News

Canary Wharf
#Collaboration #Laboratory #Life science

Will this new facility make London a life science powerhouse?

Kadans Science Partner and Canary Wharf Group (CWG), London, are developing an innovation facility providing access to fully fitted laboratories and space for developing life science companies, following the announcement of a joint venture to establish a new UK Life Sciences cluster at Canary Wharf. DDW’s Megan Thomas caught up… Read More

#Business & Investment #Exclusive Content #Opinion

CAR-T therapy
#Cancer research #CAR-T #CARsgen Therapeutics #China #Collaboration #Huadong Medicine #Immunotherapy #Myeloma #Oncology #Partnership

Partners to commercialise CAR-T product in China

CARsgen Therapeutics and Huadong Medicine (Hangzhou) will collaborate on the commercialisation of CARsgen’s BCMA CAR-T product CT053 in mainland China.  CT053 (zevorcabtagene autoleucel, Zevor-cel) is CARsgen’s lead drug candidate and an autologous CAR T cell product treating relapsed/refractory multiple myeloma (R/R MM).  Dr Zonghai Li,… Read More

#Business & Investment #News

#Collaboration #Partnership #Ubiquigent #Ubiquitin-proteasome #University of Glasgow

Industry-academia partners to exploit USP30 as a therapy target

Ubiquigent is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a (de)ubiquitylation (DUB) implicated in neurodegenerative, renal, and cardiovascular diseases.   Overseen by Professor Helen Walden, UoG, and Dr Mehmet Gundogdu, Principal Scientist at Ubiquigent, the project aims to… Read More

#News

Protesting against health inequalities
#ABPI #Collaboration #Drug discovery #Drug innovation #NHS #Pharma #UK

NHS/industry collaboration could improve access to drugs

Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues.   Analysis from the report has shown a significant variation in access to innovative medicines for patients across the UK and… Read More

#News